PharmDr. Martin Čulen, Ph.D.

Assistant professor, Department of Internal Medicine, Hematology and Oncology

correspondence Address:
Jihlavská 340/20, 625 00 Brno

office: bldg. F01B2/156
Kamenice 126/3
625 00 Brno

phone:	+420 532 23 4641
e‑mail:

social and academic networks:

Basic information

Supervision

Qualifications

Publications

Type

Total number of publications: 68

2016

Studium heterogenity mutací v průběhu terapie pacientů s akutní myeloidní leukémií

FOLTA Adam JEŽÍŠKOVÁ Ivana DVOŘÁKOVÁ Dana TOM Nikola SEMERÁD Lukáš ŠUSTKOVÁ Zuzana ČULEN Martin KOSAŘOVÁ Zdeňka ŽÁK Pavel SZOTKOWSKI Tomáš JINDRA Pavel CETKOVSKÝ Petr RÁČIL Zdeněk

Conference abstract

Year: 2016, type: Conference abstract

2015

CD26 antigen is specific for leukemic stem cells in chronic myeloid leukemia and distinguishes patient groups with different ratios of leukemic and healthy stem cells

ČULEN Martin BORSKÝ Marek NÉMETHOVÁ Veronika ŠMEJKAL Jiří JURČEK Tomáš DVOŘÁKOVÁ Dana WEINBERGEROVÁ Barbora SEMERÁD Lukáš ŽÁČKOVÁ Daniela MAYER Jiří RÁČIL Zdeněk

Conference abstract

Year: 2015, type: Conference abstract
Development of In Vitro-In Vivo Correlation/Relationship Modeling Approaches for Immediate Release Formulations Using Compartmental Dynamic Dissolution Data from "Golem'': A Novel Apparatus

ČULEN Martin TUSZYŃSKI Paweł K. POLAK Sebastian JACHOWICZ Renata MENDYK Aleksander DOHNAL Jiří

Article in Periodical

BioMed Research International, year: 2015, volume: 2015, edition: 328628, DOI
Distribution of mutations in DNMT3A gene and the suitability of mutations in R882 codon for MRD monitoring in patients with AML

JEŽÍŠKOVÁ Ivana MUSILOVÁ Milena ČULEN Martin FOLTÁNKOVÁ Veronika DVOŘÁKOVÁ Dana MAYER Jiří RÁČIL Zdeněk

Article in Periodical

International Journal of Hematology, year: 2015, volume: 102, edition: 5, DOI
DNMT3A gene: Distribution of the mutations and their stability during treatment in patients with AML

JEŽÍŠKOVÁ Ivana MUSILOVÁ Milena ČULEN Martin JANEČKOVÁ Veronika DVOŘÁKOVÁ Dana MAYER Jiří RÁČIL Zdeněk

Conference abstract

Year: 2015, type: Conference abstract
Engraftment of acute and chronic myeloid leukemia in NOD scid gamma mice

ČULEN Martin DVOŘÁKOVÁ D. SEMERÁD Lukáš ŠUSTKOVÁ Zuzana BOUCHNEROVÁ Jana PALACKOVÁ Martina MAYER Jiří RÁČIL Zdeněk

Article in Periodical

Transfuze a hematologie dnes, year: 2015, volume: 21, edition: 1
Incorporation of humanized niche as a strategy for improving leukemic engraftment in immunodeficient mice

ČULEN Martin DVOŘÁKOVÁ D. SEMERÁD Lukáš ŠUSTKOVÁ Zuzana BOUCHNEROVÁ Jana PALACKOVÁ Martina MAYER Jiří RÁČIL Zdeněk

Article in Periodical

Transfuze a hematologie dnes, year: 2015, volume: 21, edition: 1

2014

BCR-ABL1 kinase domain mutational analysis of CD34+ stem/progenitor cells in newly diagnosed CML patients by next-generation sequencing

MUSILOVÁ Milena RÁZGA Filip JURČEK Tomáš JEŽÍŠKOVÁ Ivana BORSKÝ Marek NÉMETHOVÁ Veronika ŽÁČKOVÁ Daniela ČULEN Martin DVOŘÁKOVÁ Dana MAYER Jiří RÁČIL Zdeněk

Article in Periodical

American Journal of Hematology, year: 2014, volume: 89, edition: 10, DOI

Projects

Teaching

10 reasons why you will fall in love with MU

Ask our ambassador

Read about research at MU

PharmDr. Martin Čulen, Ph.D.

2016

Studium heterogenity mutací v průběhu terapie pacientů s akutní myeloidní leukémií

2015

CD26 antigen is specific for leukemic stem cells in chronic myeloid leukemia and distinguishes patient groups with different ratios of leukemic and healthy stem cells

Development of In Vitro-In Vivo Correlation/Relationship Modeling Approaches for Immediate Release Formulations Using Compartmental Dynamic Dissolution Data from "Golem'': A Novel Apparatus

Distribution of mutations in DNMT3A gene and the suitability of mutations in R882 codon for MRD monitoring in patients with AML

DNMT3A gene: Distribution of the mutations and their stability during treatment in patients with AML

Engraftment of acute and chronic myeloid leukemia in NOD scid gamma mice

Incorporation of humanized niche as a strategy for improving leukemic engraftment in immunodeficient mice

2014

BCR-ABL1 kinase domain mutational analysis of CD34+ stem/progenitor cells in newly diagnosed CML patients by next-generation sequencing